Lawrence Fong

Academic / Other · 4 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvan Bladder Cancer	Phase 2	2017-03-07
Terminated	Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer Prostatic Neoplasms	Phase 2	2016-10-06
Completed	Neoadjuvant Atezolizumab in Localized Bladder Cancer Carcinoma, Transitional Cell	Phase 2	2016-03-29
Withdrawn	Ipilimumab and GMCSF Immunotherapy for Prostate Cancer Prostate Cancer	Phase 2	2015-06-01